ORBIMED ADVISORS LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1055951
New York, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,897,370
+$18,201,529 QoQ
Shares Held
420,600
+132.9% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#29
of 264 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $67,146,504 across 4 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (40.1% of the industry book) .
All Filings in KNSA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,897,370 | 420,600 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,695,841 | 180,599 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,721,958 | 187,199 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||